“Whole blood? Seriously?” That is the reaction Dr. Mark Yazer gets when he talks about his current favorite blood product. He is on a mission to change your mind about this “old school” product!

Dr. Mark Yazer

Dr. Mark Yazer

In the remote history of transfusion medicine, life was simple. We had exactly one product. Someone could call and say, “hey, my patient needs red cells,” and our response: “Great, we’ve got some nice whole blood for ya!” Or, “this guy could really use some plasma.” Blood bankers: “We’ve got just the thing: Whole blood!”

However, around 50 years ago, we started separating whole blood into red cells, plasma, and platelets, and the age of “component therapy” was born. Hardly anyone used whole blood (except the military, where such use continued throughout numerous US combat campaigns).

Back to the Future

In 2017, as we learn more and more about what works and what doesn’t in trauma resuscitation, some are looking again at whole blood. Dr. Mark Yazer is helping to lead the charge toward whole blood, specifically low-titer group O cold-stored whole blood, which he calls “the ideal pre- and early in-hospital resuscitation fluid!” In this episode, Mark returns to outline his case for that outrageous statement, making the following points (with time-stamps for where you can hear the points in the discussion):

  • There is a long history of transfusing whole blood [17:48]
  • Whole blood simplifies the logistics of resuscitation [25:10]
  • Whole blood is more concentrated than components [29:03]
  • Cold-stored platelets might be great! [33:37]
  • Nobody hemolyzes! [39:48]
  • Outcomes are not worse compared to component therapy [47:53]

Speaker Bio:

Dr. Mark Yazer graduated from medical school at the University of Ottawa and completed his residency in hematological pathology at the University of Alberta. He is currently a professor of pathology at the University of Pittsburgh, and the medical director of the RBC serology laboratory at the centralized transfusion service in Pittsburgh, one of the largest transfusion services in North America. He is also an adjunct professor of clinical immunology at the University of Southern Denmark. Mark has published over 150 peer reviewed papers, and is an associate editor of the journal Transfusion Medicine and the journal Hematology. He is on the editorial board of 4 other journals. He is the chairman of the AABB’s molecular testing standards unit, and the co-chairman of the AABB/THOR working group. He is on the scientific advisory/speakers board of 7 corporations, and he has given more than 200 lectures on his research worldwide. His research interests include patient blood management, blood utilization in trauma, and electronic enhancements for patient safety.

Free CE
A FREE continuing education activity for this podcast episode is available through Transfusion News Continuing Education on Wiley Health Learning. Click here for registration and access or enter www.wileyhealthlearning.com/TransfusionNews. NOTE: This episode is eligible for up to one AMA PRA Category 1 CreditTM for physicians. It is also available for up to one contact hour through the ASCLS P.A.C.E. ® Program.

Transcript Available!

Click here to download the transcript for this episode.

Never miss an episode. Subscribe on Apple Podcasts to get new episodes as they become available.


The images below are generously provided by Dr. Mark Yazer.

Pin It on Pinterest

Get More!

Get More!

New content updates

Podcasts, blogs, videos

Sign up now!

Please follow the instructions in your email to complete your subscription.